The Hemp Industries Association and a South Carolina CBD maker are trying to get U.S. Drug Enforcement Administration to clarify whether it considers temporary byproducts of hemp production a Schedule 1 substance. In a filing Monday in U.S. District Court in Washington DC, HIA and RE Botanicals ask a judge to order the DEA to […]
Hemp industry pushing DEA to address byproducts is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
